-
ELI LILLY AND COMPANY et al v. PERRIGO COMPANY et al DC CAFC
- 1:13-cv-00851
- S.D. Ind.
- Judge: Sarah Evans Barker
+1
- Filed: 05/24/2013
- Closed: 09/22/2016
- Latest Docket Entry: 01/03/2018
- PACER
- Docket updated daily
3
Plaintiffs
4
Defendants
3
Accused
Products
9
Patents-in-Suit
1,218
Days in
Litigation
-
ELI LILLY AND COMPANY et al v. PERRIGO COMPANY et al DC CAFC
- 1:13-cv-00851
- S.D. Ind.
- Judge: Sarah Evans Barker
+1
- Filed: 05/24/2013
- Closed: 09/22/2016
- Latest Docket Entry: 01/03/2018
- PACER
- Docket updated daily
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 9 |
A method of transdermal administration of a physiologically active agent to a subject including providing a system according to claim 1; applying the liquid composition including the physiologically active agent to the reservoir space; and deforming
view more
|
Enforceable and Valid (102 and 103)
Entry 462 Entry 463 |
| 10 |
A system according to claim 1 wherein the receptacle defining the reservoir space has an open top being configured to receive the liquid composition from the dispensing device through the open top.
|
Enforceable and Valid (102 and 103)
Entry 462 Entry 463 |
-
Infringement
Actavis Laboratories UT Incorporated
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,177,449 B2 |
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
|
No infringement
Entry 462
|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,419,307 B2 |
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
|
No infringement
Entry 462
|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,435,944 B2 |
11, 12
|
No infringement
Entry 462
|
Amneal Pharmaceuticals, LLC
- 4 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,177,449 B2 |
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
|
No infringement
Entry 462
|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,419,307 B2 |
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
|
No infringement
Entry 462
|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,435,944 B2 |
11, 12
|
No infringement
Entry 462
|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,807,861 B2 |
2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 13, 14, 15, 16, 17, 18, 19, 20
|
Infringement
Entry 463Entry 462 |
Lupin Limited
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,177,449 B2 |
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
|
No infringement
Entry 462
|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,419,307 B2 |
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
|
No infringement
Entry 462
|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,435,944 B2 |
11, 12
|
No infringement
Entry 462
|
Lupin Pharmaceuticals Incorporated
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,177,449 B2 |
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
|
No infringement
Entry 462
|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,419,307 B2 |
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
|
No infringement
Entry 462
|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,435,944 B2 |
11, 12
|
No infringement
Entry 462
|
Perrigo Company
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,177,449 B2 |
2, 3, 4, 5, 6, 7, 8, 9, 11, 12, 13, 14, 15, 16, 21, 22, 24, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
|
No infringement
Entry 462
|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,419,307 B2 |
5
|
No infringement
Entry 462
|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,435,944 B2 |
11, 12
|
No infringement
Entry 462
|
Perrigo Israel Pharmaceuticals Limited
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,177,449 B2 |
2, 3, 4, 5, 6, 7, 8, 9, 11, 12, 13, 14, 15, 16, 21, 22, 24, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
|
No infringement
Entry 462
|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,419,307 B2 |
5
|
No infringement
Entry 462
|
| 30mg/1.5ml testosterone metered transdermal solution | US 8,435,944 B2 |
11, 12
|
No infringement
Entry 462
|
